Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations

Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations

Summary: Antibody–drug conjugates (ADCs) represent a novel and evolving class of antineoplastic agents, constituted by monoclonal antibody linked to biologically active drugs, delivering cytotoxic compounds at the tumor site, reducing the likelihood of systemic exposure and toxicity. They are genera...

Full description

Bibliographic Details
Main Authors: Andrea D’Arienzo, Annarita Verrazzo, Martina Pagliuca, Fabiana Napolitano, Sara Parola, Martina Viggiani, Roberta Caputo, Fabio Puglisi, Mario Giuliano, Lucia Del Mastro, Grazia Arpino, Michelino De Laurentiis, Filippo Montemurro
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:EClinicalMedicine
Subjects:
Antibody drug conjugates
Breast cancer
Toxicity management
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023002900

Internet

http://www.sciencedirect.com/science/article/pii/S2589537023002900

Similar Items